23 companies

Kamada

Market Cap: ₪1.4b

Manufactures and sells plasma-derived protein therapeutics.

KMDA

₪23.89

7D

6.3%

1Y

9.2%

Nextgen Biomed

Market Cap: ₪7.2m

Develops topical treatment for psoriasis.

NXGN

₪0.49

7D

0%

1Y

-25.9%

XTL Biopharmaceuticals

Market Cap: ₪23.8m

A biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.

XTLB

₪0.027

7D

-10.0%

1Y

-47.1%

Purple Biotech

Market Cap: ₪22.3m

A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.

PPBT

₪0.012

7D

-14.3%

1Y

-81.0%

Seach Medical Group

Market Cap: ₪103.3m

Manufactures and sells medicinal cannabis products worldwide.

SEMG

₪3.12

7D

14.3%

1Y

0.5%

Blue Wave Water Capital

Market Cap: ₪8.8m

Engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes.

BLWV-M

₪1.95

7D

0%

1Y

4.8%

HBL - Hadasit Bio-Holdings

Market Cap: ₪3.3m

Operates in the biotechnology industry in Israel.

HDST-M

₪0.30

7D

0%

1Y

-41.3%

Tikun Olam-Cannbit Pharmaceuticals

Market Cap: ₪28.2m

Engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel.

TKUN

₪0.33

7D

0%

1Y

-12.6%

Smart Agro -

Market Cap: ₪10.3m

Focuses on the research and development in the field of agricultural technology in Israel.

SMAG

₪2.47

7D

0.7%

1Y

-17.7%

G.F.C Green Fields Capital

Market Cap: ₪130.5m

Does not have significant operations.

GFC-M

₪13.00

7D

-4.1%

1Y

13.0%

Clal Biotechnology Industries

Market Cap: ₪49.6m

A private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing.

CBI

₪0.32

7D

-2.5%

1Y

-9.7%

Bonus BioGroup

Market Cap: ₪293.1m

A clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.

BONS

₪0.25

7D

-7.0%

1Y

167.0%

Grace Breeding

Market Cap: ₪85.5m

An agro-tech company, develops nitrogenous and climate change stress relief products in Europe, the United States, South America, and Israel.

GRAC

₪20.67

7D

6.4%

1Y

26.5%

Matricelf

Market Cap: ₪95.5m

A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.

MTLF

₪5.61

7D

1.4%

1Y

51.6%

PlantArc Bio

Market Cap: ₪7.3m

Operates as an Ag-Bio company for the crop protection and yield enhancement.

PLNT

₪2.21

7D

0.8%

1Y

-21.8%

Evogene

Market Cap: ₪29.1m

Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.

EVGN

₪3.34

7D

-6.3%

1Y

-29.2%

BioLight Life Sciences

Market Cap: ₪33.9m

An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.

BOLT

₪3.75

7D

-1.4%

1Y

-22.6%

InterCure

Market Cap: ₪257.0m

Engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

INCR

₪4.70

7D

16.4%

1Y

-7.5%

Y.B Urban Renewal - Residential Development

Market Cap: ₪31.3m

Engages in the cultivation and production of medical cannabis.

YBRD

₪7.60

7D

3.6%

1Y

-23.0%

Nextage Therapeutics

Market Cap: ₪26.3m

A pharmaceutical company, develops cannabinoid-based products in Israel and internationally.

NXTG

₪0.78

7D

0%

1Y

0.8%

Rekah Pharmaceutical Industry

Market Cap: ₪132.5m

Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.

REKA

₪11.61

7D

-0.9%

1Y

-16.6%

BioLineRx

Market Cap: ₪44.4m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

BLRX

₪0.017

7D

0%

1Y

-70.7%

Can-Fite BioPharma

Market Cap: ₪51.2m

A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.

CANF

₪0.01

7D

0%

1Y

-44.4%